Erik Nilsson is president of Seattle-based Insilicos, a biotech company developing diagnostics for cardiovascular disease. A serial entrepreneur, he has participated in two startups at the executive level and a couple more as a worker bee. Erik is currently principal investigator on three NIH grants related to Insilicos' work. He is an active member of the Washington Biotechnology and Biomedical Association.
Erik lives happily in Seattle with his family. When not at work, he can be found riding bicycle ultramarathons, collecting Northwest Coast Indian art, or building strange scientific instruments with his son. He can sail a boat, build a bicycle wheel, decipher a letter in Swedish, and do any kind of house wiring.
Cloud computing and biotech are the two most important nonlinearly-growing economic sectors. These two sectors intersect in Seattle in a unique way that has important implications for all involved. Small changes... Read more »